Cargando…

Aberrant intracellular metabolism of T‐DM1 confers T‐DM1 resistance in human epidermal growth factor receptor 2‐positive gastric cancer cells

Trastuzumab emtansine (T‐DM1), an antibody–drug conjugate (ADC) consisting of human epidermal growth factor receptor 2 (HER2)‐targeted mAb trastuzumab linked to antimicrotubule agent mertansine (DM1), has been approved for the treatment of HER2‐positive metastatic breast cancer. Acquired resistance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hongbin, Wang, Wenqian, Xu, Yongping, Yang, Yong, Chen, Xiaoyan, Quan, Haitian, Lou, Liguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497802/ https://www.ncbi.nlm.nih.gov/pubmed/28388007 http://dx.doi.org/10.1111/cas.13253

Ejemplares similares

YES1 amplification confers trastuzumab–emtansine (T-DM1) resistance in HER2-positive cancer
por: Wang, Lei, et al.
Publicado: (2020)

STAT3 activation confers trastuzumab‐emtansine (T‐DM1) resistance in HER2‐positive breast cancer
por: Wang, Lei, et al.
Publicado: (2018)

I-14 Molecular pathomechanism of DM2/PROMM: similarities and differences between DM1 and DM2
por: Meola, G.
Publicado: (2011)

Clinical and biochemical characteristics of familial type 1 diabetes mellitus (FT1DM) compared to non-familial type 1 DM (NFT1DM)
por: Alyafei, Fawzia, et al.
Publicado: (2018)

Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer
por: Zhang, Jinghui, et al.
Publicado: (2021)

DM-Ice
por: Seo, Seon-Hee
Publicado: (2011)

DM at the LHC, an overview
por: Wang, Renjie
Publicado: (2019)

Correction: Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer
por: Zhang, Jinghui, et al.
Publicado: (2023)

Emerging Roles of Exosomes in T1DM
por: Pang, Haipeng, et al.
Publicado: (2020)

The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells
por: Liu, Peipei, et al.
Publicado: (2020)

Consequences of DM/antiDM Oscillations for Asymmetric WIMP Dark Matter
por: Cirelli, Marco, et al.
Publicado: (2011)

Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
por: Kloc, Małgorzata, et al.
Publicado: (2020)

Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice
por: Oana, Kosuke, et al.
Publicado: (2013)

Peptidome Analysis of Pancreatic Tissue Derived from T1DM Mice: Insights into the Pathogenesis and Clinical Treatments of T1DM
por: Zhang, Fan, et al.
Publicado: (2021)

Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4
por: Kalinovsky, Daniel V., et al.
Publicado: (2023)

The ArDM experiment
por: Haranczyk, M, et al.
Publicado: (2010)

Searches for DM with ATLAS
por: Gonzalez Fernandez, Sergio
Publicado: (2020)

DM Authors no. 8
Publicado: (1977)

A Review of Economic Models Submitted to NICE’s Technology Appraisal Programme, for Treatments of T1DM & T2DM
por: Daly, Marie-Josée, et al.
Publicado: (2022)

CMB spectral distortions as a probe of DM-$\gamma$ and DM-$\nu$ interactions
por: Diacoumis, James
Publicado: (2018)

The Prevalence and Outcome of pre-DM/DM in an Urban HIV Primary Care Clinic
por: Jeong, Young-Gwang, et al.
Publicado: (2017)

Increasing incidence of DM type 1 in Indonesia
por: Pulungan, Aman
Publicado: (2013)

HER2 expression and efficacy of T-DM1
por: Montemurro, Filippo
Publicado: (2014)

Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer
por: Ma, Bo, et al.
Publicado: (2016)

Summary of searches for exotics and supersymmetry at ATLAS (Aspen DM conference)
por: Bachacou, H
Publicado: (2014)

Whether or Not the Effects of Curcuma longa Supplementation Are Associated with Physical Exercises in T1DM and T2DM: A Systematic Review
por: Sena-Júnior, Ailton Santos, et al.
Publicado: (2020)

Burden of T1DM and T2DM among adolescents in Western Europe, 1990-2019: results from the GBD 2019
por: Armocida, B, et al.
Publicado: (2023)

Cell-free expression, purification, and ligand-binding analysis of Drosophila melanogaster olfactory receptors DmOR67a, DmOR85b and DmORCO
por: Tegler, Lotta Tollstoy, et al.
Publicado: (2015)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)

DM Search at the HL-LHC
por: Barranco Navarro, Laura
Publicado: (2019)

T2DM: Why Epigenetics?
por: Fradin, Delphine, et al.
Publicado: (2011)

Constraining DM properties with SPI
por: Boyarsky, Alexey, et al.
Publicado: (2007)

* Infos DM auteurs no. 7 *
Publicado: (1977)

Molecular mechanisms in DM1 — a focus on foci
por: Pettersson, Olof Joakim, et al.
Publicado: (2015)

Characterization of T‐DM1‐resistant breast cancer cells
por: Sauveur, Juliette, et al.
Publicado: (2020)

The NLRP3 Inflammasome and Its Role in T1DM
por: Sun, Xiaoxiao, et al.
Publicado: (2020)

Oxidative stress parameters and keap 1 variants in T2DM: Association with T2DM, diabetic neuropathy, diabetic retinopathy, and obesity
por: Khalili, Farnaz, et al.
Publicado: (2021)

Fine mapping of a novel QTL DM9.1 conferring downy mildew resistance in melon
por: Zhang, Xuejun, et al.
Publicado: (2023)

Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer
por: Hunter, Francis W., et al.
Publicado: (2019)

pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity
por: Jiang, Wei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uu3m7u6qk0q319k6tmoe2r1cj9